Roche considers flu drug partners

Drug firm Roche may allow other companies to produce its antiviral drug Tamiflu under licence to help combat a potential flu pandemic.
The Swiss firm is considering ways of boosting output of Tamiflu, the main treatment for the deadly strain of bird flu which struck Asia last year.

Roche is now producing Tamiflu at 13 sites worldwide and has received orders for the drug from 40 countries.

The World Health Organization advised countries to stockpile supplies.

link to full article from BBC.com

tamiflu